BRPI0917212A2 - compostos de fenantrenona, seus usos na preparação de composições, e composições compreendendo os referidos compostos - Google Patents

compostos de fenantrenona, seus usos na preparação de composições, e composições compreendendo os referidos compostos

Info

Publication number: BRPI0917212A2
Authority: BR; Brazil
Prior art keywords: compositions; compounds; preparation; phenanthrenone; phenanthrenone compounds
Prior art date: 2008-07-28

Application number

BRPI0917212A

Other languages

English (en)

Inventor

Paul Vicent Rucker

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-07-28

Filing date

2009-07-14

Publication date

2015-11-10

2009-07-14 Application filed by Pfizer filed Critical Pfizer

2015-11-10 Publication of BRPI0917212A2 publication Critical patent/BRPI0917212A2/pt

Links

239000000203 mixture Substances 0.000 title 2
IQMTVJBLQXREOP-UHFFFAOYSA-N 2h-phenanthren-1-one Chemical class C1=CC2=CC=CC=C2C2=C1C(=O)CC=C2 IQMTVJBLQXREOP-UHFFFAOYSA-N 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Orthopedic Medicine & Surgery (AREA)
Hospice & Palliative Care (AREA)
Transplantation (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Ophthalmology & Optometry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Steroid Compounds (AREA)
Pyridine Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

BRPI0917212A 2008-07-28 2009-07-14 compostos de fenantrenona, seus usos na preparação de composições, e composições compreendendo os referidos compostos BRPI0917212A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US8409508P	2008-07-28	2008-07-28
PCT/IB2009/053044 WO2010013158A1 (en)	2008-07-28	2009-07-14	Phenanthrenone compounds, compositions and methods

Publications (1)

Publication Number	Publication Date
BRPI0917212A2 true BRPI0917212A2 (pt)	2015-11-10

Family

ID=41037773

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0917212A BRPI0917212A2 (pt)	2008-07-28	2009-07-14	compostos de fenantrenona, seus usos na preparação de composições, e composições compreendendo os referidos compostos

Country Status (38)

Country	Link
US (2)	US8148409B2 (pt)
EP (1)	EP2307375B1 (pt)
JP (1)	JP4823397B1 (pt)
KR (1)	KR101377860B1 (pt)
CN (1)	CN102112446B (pt)
AP (1)	AP2744A (pt)
AR (1)	AR072535A1 (pt)
AU (1)	AU2009278029B2 (pt)
BR (1)	BRPI0917212A2 (pt)
CA (1)	CA2729578C (pt)
CL (1)	CL2011000141A1 (pt)
CO (1)	CO6290761A2 (pt)
CR (1)	CR20110012A (pt)
CU (1)	CU23983B1 (pt)
DK (1)	DK2307375T3 (pt)
DO (1)	DOP2011000029A (pt)
EA (1)	EA018024B1 (pt)
EC (1)	ECSP11010795A (pt)
ES (1)	ES2527137T3 (pt)
GE (1)	GEP20125640B (pt)
GT (1)	GT201100026A (pt)
HR (1)	HRP20150021T1 (pt)
IL (1)	IL210492A (pt)
MA (1)	MA32512B1 (pt)
MX (1)	MX2011001053A (pt)
NI (1)	NI201100028A (pt)
NZ (1)	NZ590559A (pt)
PE (1)	PE20110559A1 (pt)
PL (1)	PL2307375T3 (pt)
PT (1)	PT2307375E (pt)
RS (1)	RS53747B1 (pt)
SI (1)	SI2307375T1 (pt)
SV (1)	SV2011003821A (pt)
TW (1)	TWI374878B (pt)
UA (1)	UA99198C2 (pt)
UY (1)	UY32011A (pt)
WO (1)	WO2010013158A1 (pt)
ZA (1)	ZA201101520B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR112013033777A2 (pt) *	2011-03-15	2016-09-13	Abbvie Inc	moduladores de receptor de hormônio nuclear
TW201422590A (zh)	2012-09-07	2014-06-16	Abbvie Inc	雜環核激素受體調節劑
EP2935284A4 (en)	2012-12-21	2016-04-27	Abbvie Inc	HETEROCYCLIC MODULATORS OF HORMONE NUCLEAR RECEPTORS

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL207610B1 (pl)	1999-04-30	2011-01-31	Pfizer Prod Inc	Związki modulujące receptory glukokortykoidowe, ich zastosowanie do wytwarzania leku i środek farmaceutyczny
JP4100908B2 (ja)	1999-07-30	2008-06-11	エーザイ・アール・アンド・ディー・マネジメント株式会社	塩基性抗生物質・無機酸塩の製造法およびシュウ酸塩中間体
EP1201649B1 (en)	2000-10-28	2006-05-31	Pfizer Products Inc.	Glucocorticoid receptor modulators
ES2246292T3 (es) *	2000-10-30	2006-02-16	Pfizer Products Inc.	Moduladores de receptor glucocorticoide.
WO2004005229A1 (en) *	2002-07-08	2004-01-15	Pfizer Products Inc.	Modulators of the glucocorticoid receptor
US7449458B2 (en)	2005-01-19	2008-11-11	Rigel Pharmaceuticals, Inc.	Prodrugs of 2,4-pyrimidinediamine compounds and their uses
GB0613836D0 (en)	2006-07-13	2006-08-23	Univ Greenwich	New medical use of triazine derivatives
WO2008064274A1 (en)	2006-11-21	2008-05-29	Rigel Pharmaceuticals, Inc.	Prodrug salts of 2, 4-pyrimidinediamine compounds and their uses
EP2121029A2 (en)	2006-12-05	2009-11-25	Neurogesx, Inc.	Prodrugs and methods of making and using the same
UZ4378C (en) *	2007-02-02	2011-07-29	Pfizer Prod Inc	Tricyclic compounds and their use as glucocorticoid receptor modulators
DK2114970T3 (da) *	2007-02-02	2011-09-19	Pfizer Prod Inc	Tricykliske forbindelser og deres anvendelse som glucocorticoidreceptormodulatorer

2009
- 2009-07-14 BR BRPI0917212A patent/BRPI0917212A2/pt not_active IP Right Cessation
- 2009-07-14 EA EA201100080A patent/EA018024B1/ru not_active IP Right Cessation
- 2009-07-14 EP EP09786592.7A patent/EP2307375B1/en active Active
- 2009-07-14 UA UAA201100440A patent/UA99198C2/ru unknown
- 2009-07-14 PT PT97865927T patent/PT2307375E/pt unknown
- 2009-07-14 CA CA2729578A patent/CA2729578C/en not_active Expired - Fee Related
- 2009-07-14 SI SI200931100T patent/SI2307375T1/sl unknown
- 2009-07-14 CN CN200980129538XA patent/CN102112446B/zh not_active Expired - Fee Related
- 2009-07-14 MX MX2011001053A patent/MX2011001053A/es active IP Right Grant
- 2009-07-14 NZ NZ590559A patent/NZ590559A/en not_active IP Right Cessation
- 2009-07-14 KR KR1020117002134A patent/KR101377860B1/ko not_active Expired - Fee Related
- 2009-07-14 DK DK09786592.7T patent/DK2307375T3/en active
- 2009-07-14 GE GEAP200912074A patent/GEP20125640B/en unknown
- 2009-07-14 AP AP2011005562A patent/AP2744A/xx active
- 2009-07-14 JP JP2011520622A patent/JP4823397B1/ja not_active Expired - Fee Related
- 2009-07-14 HR HRP20150021AT patent/HRP20150021T1/hr unknown
- 2009-07-14 AU AU2009278029A patent/AU2009278029B2/en not_active Ceased
- 2009-07-14 PL PL09786592T patent/PL2307375T3/pl unknown
- 2009-07-14 RS RS20150019A patent/RS53747B1/sr unknown
- 2009-07-14 PE PE2011000098A patent/PE20110559A1/es not_active Application Discontinuation
- 2009-07-14 ES ES09786592.7T patent/ES2527137T3/es active Active
- 2009-07-14 WO PCT/IB2009/053044 patent/WO2010013158A1/en not_active Ceased
- 2009-07-20 US US12/505,932 patent/US8148409B2/en not_active Expired - Fee Related
- 2009-07-27 TW TW098125265A patent/TWI374878B/zh not_active IP Right Cessation
- 2009-07-27 AR ARP090102852A patent/AR072535A1/es unknown
- 2009-07-28 UY UY0001032011A patent/UY32011A/es not_active Application Discontinuation
2011
- 2011-01-06 IL IL210492A patent/IL210492A/en not_active IP Right Cessation
- 2011-01-10 CR CR20110012A patent/CR20110012A/es unknown
- 2011-01-21 CL CL2011000141A patent/CL2011000141A1/es unknown
- 2011-01-26 NI NI201100028A patent/NI201100028A/es unknown
- 2011-01-27 GT GT201100026A patent/GT201100026A/es unknown
- 2011-01-27 CO CO11009253A patent/CO6290761A2/es active IP Right Grant
- 2011-01-27 DO DO2011000029A patent/DOP2011000029A/es unknown
- 2011-01-28 EC EC2011010795A patent/ECSP11010795A/es unknown
- 2011-01-28 MA MA33568A patent/MA32512B1/fr unknown
- 2011-01-28 SV SV2011003821A patent/SV2011003821A/es unknown
- 2011-01-28 CU CU2011000020A patent/CU23983B1/es active IP Right Grant
- 2011-02-25 ZA ZA2011/01520A patent/ZA201101520B/en unknown
2012
- 2012-02-27 US US13/406,446 patent/US8552035B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
RS53747B1 (sr)	2015-06-30
US8552035B2 (en)	2013-10-08
TWI374878B (en)	2012-10-21
CN102112446A (zh)	2011-06-29
ECSP11010795A (es)	2011-02-28
CU20110020A7 (es)	2011-12-28
HK1154245A1 (en)	2012-04-13
SI2307375T1 (sl)	2015-02-27
SV2011003821A (es)	2011-07-28
AP2744A (en)	2013-09-30
UY32011A (es)	2010-02-26
ZA201101520B (en)	2011-10-26
US8148409B2 (en)	2012-04-03
CL2011000141A1 (es)	2011-06-17
GT201100026A (es)	2013-12-10
US20100069444A1 (en)	2010-03-18
PT2307375E (pt)	2015-01-14
IL210492A0 (en)	2011-03-31
JP2011529103A (ja)	2011-12-01
EP2307375B1 (en)	2014-11-19
KR20110022091A (ko)	2011-03-04
DOP2011000029A (es)	2014-07-31
EP2307375A1 (en)	2011-04-13
CA2729578A1 (en)	2010-02-04
JP4823397B1 (ja)	2011-11-24
CR20110012A (es)	2011-02-10
MA32512B1 (fr)	2011-07-03
AP2011005562A0 (en)	2011-02-28
MX2011001053A (es)	2011-04-21
PL2307375T3 (pl)	2015-03-31
CU23983B1 (es)	2014-03-26
GEP20125640B (en)	2012-09-10
AU2009278029B2 (en)	2012-05-03
AU2009278029A1 (en)	2010-02-04
UA99198C2 (ru)	2012-07-25
HRP20150021T1 (xx)	2015-03-27
TW201014823A (en)	2010-04-16
ES2527137T3 (es)	2015-01-21
NI201100028A (es)	2011-08-05
PE20110559A1 (es)	2011-08-06
NZ590559A (en)	2011-09-30
EA201100080A1 (ru)	2011-08-30
US20120157502A1 (en)	2012-06-21
WO2010013158A1 (en)	2010-02-04
IL210492A (en)	2015-04-30
CN102112446B (zh)	2012-10-31
EA018024B1 (ru)	2013-04-30
AR072535A1 (es)	2010-09-01
KR101377860B1 (ko)	2014-03-25
CA2729578C (en)	2014-05-27
CO6290761A2 (es)	2011-06-20
DK2307375T3 (en)	2014-12-08

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-03-26	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2019-05-07	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 10A ANUIDADE.
2019-08-27	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2522 DE 07-05-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
BRPI0809103A2 (pt)	2016-08-02	composições de magnésio e seus usos
BR112013012132A2 (pt)	2016-09-27	composição compreendendo proteínas e oligossacarídeos hidrolisados, e seus usos
PT2473528E (pt)	2015-03-04	Formulações estáveis de polipéptidos e seus usos
HRP20170926T1 (hr)	2017-09-22	Antisens kompozicije i postupci za pripremu i uporabu istih
BRPI1009481A2 (pt)	2016-03-01	compostos de 2-acetamido-5-aril-1,2,4-triazolonas substituídas, seu processo de preparação, seu uso e medicamento compreendendo os mesmos
BR112013012190A2 (pt)	2017-11-07	composições adesivas e seus usos
BR112012002331A2 (pt)	2019-09-24	composição antiviral, composição farmacêutica e uso de quantidade efetiva de composição farmacêutica
BR112013012129A2 (pt)	2016-09-27	composições de adesivos e seus usos
PT3812360T (pt)	2023-12-28	Compostos de monoclorotrifluoropropeno e composições e métodos utilizando os mesmos
BRPI0813244A2 (pt)	2014-12-23	Compostos e seus usos 708
BRPI0908175A2 (pt)	2016-07-05	derivados de polimixina e composição farmacêuticas contendo os derivados de polimixina seus usos e métodos de preparação
BRPI0915897A2 (pt)	2015-11-03	compostos derivados triazóis, composições farmacêuticas e combinações dos mesmos e seus usos
BRPI1011482A2 (pt)	2016-03-22	composição para uso na redução da transmissão de patógenos humanos
BRPI1009372A2 (pt)	2016-05-31	compostos, composição farmacêutica e respectivos usos
BRPI0819047A2 (pt)	2015-05-05	"composição, seu processo de preparação e seus usos"
BRPI0924427A2 (pt)	2016-01-26	composição farmacêutica de liberação controlada, seu processo de preparação e uso da mesma
BRPI0810863A2 (pt)	2014-10-07	Uso de hidrolisados de proteína para estabilizar formulações de detergente de metaloprotease.
EP2486905A4 (en)	2013-04-10	HIGH-DRAWN VOIDABLE ARTICLE
BRPI0814427A2 (pt)	2015-01-06	Aldiminas, seus processos de preparação, composições curáveis compreendendo as mesmas, composto de aldimono av, usos e artigos relacionados
ATE496849T1 (de)	2011-02-15	Getränkeinhaltstoffkapsel
BRPI0913640A2 (pt)	2016-08-16	substâncias policrômicas e seus usos
BRPI1008045A2 (pt)	2016-03-15	derivados de aminotetralina, composições farmacêuticas contendo-os, e seu uso em terapia
BRPI0908948A2 (pt)	2019-09-24	preparação de materiais de dessulfurização
BRPI1010540A2 (pt)	2016-03-15	"anticorpos especéficos para dkk-1 e seus usos"
BRPI0814709A2 (pt)	2017-06-06	compostos, seus usos em aplicações cosméticas e cosmecêuticas e composições contendo os mesmos